DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 021253
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in ZYPREXA is olanzapine pamoate. There are thirty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the olanzapine pamoate profile page.
Summary for 021253
Tradename: | ZYPREXA |
Applicant: | Lilly |
Ingredient: | olanzapine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 021253
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYPREXA | olanzapine | INJECTABLE;INTRAMUSCULAR | 021253 | NDA | Eli Lilly and Company | 0002-7597 | 0002-7597-01 | 1 VIAL in 1 CARTON (0002-7597-01) > 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR | Strength | 10MG/VIAL | ||||
Approval Date: | Mar 29, 2004 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 021253
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | ZYPREXA | olanzapine | INJECTABLE;INTRAMUSCULAR | 021253-001 | Mar 29, 2004 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription